A type II 5-alpha reductase inhibitor that prevents testosterone from converting into DHT inside the hair follicle.

DHT is the primary driver of follicular miniaturization in androgenetic alopecia. Finasteride reduces intrafollicular DHT by approximately 70%, stopping the shrinkage cycle and allowing follicles to return to a healthy growth phase. Topical formulas deliver it directly to the scalp with significantly less systemic absorption than oral pills.

A dual-isoenzyme 5-alpha reductase inhibitor that blocks both type I and type II enzymes — more potent than finasteride.

While finasteride blocks only type II (reducing DHT ~70%), dutasteride blocks both isoforms and suppresses serum DHT by up to 90%. This makes it the most potent available oral DHT blocker — especially critical for men on TRT, where exogenous testosterone further elevates DHT levels. It halts follicular miniaturization more completely and allows more robust follicle recovery.

A naturally occurring dicarboxylic acid that mildly inhibits 5-alpha reductase locally at the scalp — without systemic hormonal effects.

Azelaic acid reduces intrafollicular DHT production at the scalp level only, making it ideal for those who want DHT blockade without any systemic exposure. It also reduces perifollicular oxidative and inflammatory burden, creating a healthier environment for the follicle. Used in women's formulas where systemic DHT blockers like finasteride are contraindicated.

A naturally occurring sex hormone that competes at androgen receptors in the follicular unit and independently inhibits 5-alpha reductase.

Progesterone provides a second layer of androgen blockade by blocking DHT from binding to androgen receptors in the follicle and inhibiting the enzyme that converts testosterone to DHT. When combined with finasteride in a topical formula, it creates dual-pathway DHT protection. In women, it also counteracts estrogen dominance that can contribute to hair thinning.

A potassium channel opener originally developed as a blood pressure medication, now the most widely studied topical and oral hair growth agent.

Minoxidil relaxes smooth muscle in perifollicular blood vessels, dramatically increasing nutrient and oxygen delivery to dormant follicles. It also directly stimulates dermal papilla cell activity and prolongs the anagen (growth) phase — moving follicles out of the resting phase and back into active growth. Available in topical and oral forms; oral minoxidil provides systemic vasodilation for diffuse thinning.

A naturally occurring copper-binding tripeptide (Glycyl-L-Histidyl-L-Lysine) that declines with age and plays a key role in tissue repair and follicular regeneration.

GHK-Cu delivers bioavailable copper that activates lysyl oxidase — the enzyme responsible for extracellular matrix remodeling around the follicle. It upregulates VEGF to improve perifollicular microcirculation, suppresses TGF-beta-1 (which prematurely pushes follicles into regression), and directly extends the anagen phase. It rebuilds the entire follicular microenvironment rather than targeting a single pathway.

A prescription-strength retinoid (vitamin A derivative) that increases cell turnover, remodels the stratum corneum, and enhances scalp drug penetration.

Tretinoin increases stratum corneum permeability, significantly improving the absorption of co-delivered actives like minoxidil and finasteride. It also supports follicular keratinocyte regulation and cell renewal at the scalp level — helping maintain a healthier follicular unit. When combined with minoxidil, tretinoin amplifies its effectiveness by improving how much of the drug actually reaches the follicle.

A mid-potency topical corticosteroid that suppresses inflammatory cytokines and immune activation in the perifollicular tissue.

Chronic perifollicular inflammation is a major accelerant of follicular miniaturization — the immune system attacks and compresses follicles over time. Triamcinolone suppresses this local inflammatory environment, halting the inflammatory cascade that drives conditions including androgenetic alopecia, alopecia areata, and seborrheic dermatitis-associated shedding. By reducing inflammatory pressure on the follicle, it allows the growth signal to take hold.

A fluorinated topical corticosteroid that suppresses scalp inflammation and perifollicular immune overactivation contributing to hair loss.

Fluocinolone acetonide specifically targets the inflammatory alopecias — conditions where immune-mediated inflammation directly destroys follicles or pushes them prematurely into the resting phase. By suppressing perifollicular immune activation, it creates the environment needed for minoxidil and other growth agents to work. Particularly effective in inflammatory hair loss patterns that do not respond to DHT blockers alone.

The primary estrogen hormone, applied topically to the scalp to activate estrogen receptors in the outer root sheath and dermal papilla.

Estradiol plays a key protective role in the female hair follicle — it extends the anagen (growth) phase and directly opposes androgenic follicular signaling. Estrogen receptors in the outer root sheath respond to estradiol by slowing the progression from growth to regression. Topical application delivers it precisely where it's needed without significant systemic absorption. Loss of estradiol during perimenopause is one of the primary drivers of female-pattern hair thinning.

The active form of thyroid hormone (triiodothyronine), applied topically to activate thyroid receptors in the dermal papilla cells of the hair follicle.

Thyroid hormone receptors in the dermal papilla are directly involved in regulating the hair growth cycle. Liothyronine supports follicular metabolic activity, protein synthesis, and anagen maintenance at the cellular level. Even when systemic thyroid levels appear normal, local follicular thyroid receptor activity can be suboptimal. Topical T3 addresses this microenvironment deficiency directly at the follicle root.

Low-dose topical testosterone applied to the scalp to support androgen balance and follicular growth signaling in specific male hair loss formulas.

Paradoxically, while excess DHT drives follicular miniaturization, some level of androgen signaling is necessary for follicular activity. Low-dose topical testosterone in combination with DHT blockers (azelaic acid, progesterone) helps maintain follicular androgen tone without elevating intrafollicular DHT — supporting the dermal papilla's growth signaling while the formula simultaneously controls DHT at the scalp level.

A water-soluble B vitamin essential for keratin biosynthesis and fatty acid production in the hair follicle.

Keratin is the primary structural protein of the hair shaft. Biotin is a required cofactor for the carboxylase enzymes that drive keratin synthesis — without adequate biotin, hair becomes brittle, thin, and prone to breakage. It also supports fatty acid metabolism required for healthy follicular cell membrane integrity. Added to both topical and oral formulas to reinforce the structural quality of the hair being grown.

A highly bioavailable form of iron that replenishes depleted iron stores required for cellular DNA synthesis in rapidly dividing hair follicle cells.

The hair follicle matrix contains some of the fastest-dividing cells in the human body. Iron is required for ribonucleotide reductase — the rate-limiting enzyme in DNA synthesis for these cells. Iron deficiency is one of the most common and underdiagnosed causes of diffuse hair shedding (telogen effluvium) in both men and women. Restoring iron stores is often the single most impactful intervention for deficiency-driven hair loss.

The most bioavailable form of vitamin B12, essential for methylation reactions, red blood cell formation, and follicular cell proliferation.

B12 deficiency impairs DNA synthesis and red blood cell production, reducing the oxygen-carrying capacity of blood reaching the follicle. It supports the methylation cycle that regulates gene expression in follicular stem cells, and drives the cell proliferation needed to sustain active hair growth. Methylcobalamin is preferred over cyanocobalamin because it is immediately usable without conversion by the liver.

An essential trace mineral required for enzymatic activity, protein synthesis, and immune regulation within follicular tissue.

Zinc is a cofactor for over 300 enzymes involved in protein and DNA synthesis — both critical for the rapidly dividing cells of the hair matrix. It also inhibits 5-alpha reductase at physiological concentrations, providing mild androgen modulation. Zinc deficiency is associated with diffuse hair loss and delayed follicular recovery. It also supports the structural integrity of the hair protein network and regulates sebum production on the scalp.

A potent antioxidant and iron-absorption enhancer that converts ferric iron to the absorbable ferrous form in the gastrointestinal tract.

Vitamin C dramatically improves the bioavailability of iron from supplemental sources by converting ferric iron (Fe³⁺) to ferrous iron (Fe²⁺) — the only form absorbable in the small intestine. This makes it a critical co-factor in any iron-repletion protocol. Vitamin C also supports collagen synthesis in the perifollicular connective tissue sheath and provides antioxidant protection against free radical oxidative stress in the scalp environment.

A fat-soluble antioxidant that protects perifollicular lipid membranes from oxidative damage and supports the follicular microenvironment.

The perifollicular environment is exposed to significant oxidative stress from UV radiation, pollution, and inflammatory signaling. Vitamin E scavenges free radicals in the lipid bilayers surrounding follicular cells, preventing membrane damage that can impair follicular function and trigger premature catagen (regression). Applied topically, it also improves scalp hydration and tissue integrity, creating a more favorable environment for the growth-promoting actives to work.